ANQUAGEN, an innovative biotechnology company, passionately creating rational science based solutions rapidly, to cater underserved or unmet needs for the health and well being of animals, fish and birds. ©
Mission: Global leader in translational research of innovative groundbreaking proprietary technologies available, to rapidly develop Safe, Market-differentiating and Effective biological products to underserved or unmet needs in Animal, Aqua and Poultry Health. ©
“Fast - Effective - Perpetual”
ANQUAGEN, a young innovative late-stage R&D biotechnology company with focus on rapidly commercializing rational science based biologics discoveries for underserved or unmet needs in vaccines for animals, birds and cultured fish. The company has unique exclusive proprietary platform technologies as well as novel vaccine technologies in its portfolio. Anquagen believes that is well set to experience a rapid growth in the Animal and Aqua Health space and aspires to become the Global Leader in the Next Generation Veterinary and Aquaculture Vaccines.
Company Details
- Founded
- -
- Address
- Overland Park, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.anquagen.com
- HQ
- Overland Park
Anquagen Questions
Anquagen's website is http://www.anquagen.com
Anquagen's LinkedIn profile is https://www.linkedin.com/company/anquagen
Anquagen's industry is
Biotechnology Research
Anquagen's top competitors are
Impact Poultry Products,
Poular Biologicals,
Yebio Bioengineering Co., Ltd Of Qingdao,
Thama-Vet Llc,
Pasouk,
Tlaxovet Group Of Company,
Forward Solutions,
Aviaxin,
Golden Harvest,
Anquap.
Anquagen's categories are Biotechnology Research
Anquagen's founding year is 2011
